RPg Family Wealth Advisory LLC Boosts Position in Zoetis Inc (ZTS)

RPg Family Wealth Advisory LLC boosted its position in shares of Zoetis Inc (NYSE:ZTS) by 24,302.0% in the fourth quarter, Holdings Channel reports. The fund owned 48,804 shares of the company’s stock after purchasing an additional 48,604 shares during the quarter. Zoetis comprises 4.1% of RPg Family Wealth Advisory LLC’s investment portfolio, making the stock its 8th biggest holding. RPg Family Wealth Advisory LLC’s holdings in Zoetis were worth $4,175,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Whittier Trust Co. grew its holdings in Zoetis by 3.2% during the fourth quarter. Whittier Trust Co. now owns 4,039 shares of the company’s stock valued at $345,000 after purchasing an additional 124 shares during the period. North Star Investment Management Corp. grew its holdings in Zoetis by 0.6% during the fourth quarter. North Star Investment Management Corp. now owns 22,525 shares of the company’s stock valued at $1,927,000 after purchasing an additional 125 shares during the period. Sandy Spring Bank grew its holdings in Zoetis by 0.4% during the fourth quarter. Sandy Spring Bank now owns 29,716 shares of the company’s stock valued at $2,542,000 after purchasing an additional 125 shares during the period. InterOcean Capital LLC grew its holdings in Zoetis by 5.0% during the fourth quarter. InterOcean Capital LLC now owns 2,945 shares of the company’s stock valued at $252,000 after purchasing an additional 139 shares during the period. Finally, Harvest Management LLC grew its holdings in Zoetis by 8.0% during the fourth quarter. Harvest Management LLC now owns 2,700 shares of the company’s stock valued at $231,000 after purchasing an additional 200 shares during the period. Institutional investors own 89.98% of the company’s stock.

In other news, insider Roxanne Lagano sold 2,000 shares of the company’s stock in a transaction dated Monday, December 31st. The stock was sold at an average price of $85.30, for a total value of $170,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Juan Ramon Alaix sold 312,109 shares of the company’s stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $94.06, for a total value of $29,356,972.54. The disclosure for this sale can be found here. In the last ninety days, insiders sold 406,209 shares of company stock valued at $38,120,373. Corporate insiders own 0.35% of the company’s stock.

Several analysts have issued reports on the company. Stifel Nicolaus raised Zoetis from a “hold” rating to a “buy” rating and boosted their price target for the company from $97.00 to $110.00 in a report on Monday, March 4th. BMO Capital Markets boosted their price target on Zoetis from $93.00 to $101.00 and gave the company a “market perform” rating in a report on Monday, February 25th. Zacks Investment Research raised Zoetis from a “sell” rating to a “hold” rating in a report on Saturday, February 16th. Finally, UBS Group assumed coverage on Zoetis in a report on Wednesday, January 23rd. They set a “neutral” rating and a $86.00 price target for the company. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $98.85.

Shares of NYSE ZTS traded up $0.24 during mid-day trading on Friday, reaching $96.44. The company’s stock had a trading volume of 10,400 shares, compared to its average volume of 2,519,696. The firm has a market cap of $46.06 billion, a price-to-earnings ratio of 30.78, a price-to-earnings-growth ratio of 1.74 and a beta of 0.92. The company has a quick ratio of 2.46, a current ratio of 3.60 and a debt-to-equity ratio of 2.95. Zoetis Inc has a 52 week low of $77.00 and a 52 week high of $97.95.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 14th. The company reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The firm had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.53 billion. Zoetis had a return on equity of 73.85% and a net margin of 24.51%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.69 earnings per share. Research analysts expect that Zoetis Inc will post 3.46 EPS for the current fiscal year.

Zoetis declared that its Board of Directors has approved a share repurchase plan on Wednesday, December 12th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 4.7% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Thursday, April 18th will be paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Wednesday, April 17th. Zoetis’s dividend payout ratio (DPR) is 21.09%.

ILLEGAL ACTIVITY WARNING: “RPg Family Wealth Advisory LLC Boosts Position in Zoetis Inc (ZTS)” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2019/03/15/rpg-family-wealth-advisory-llc-boosts-position-in-zoetis-inc-zts.html.

Zoetis Company Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

See Also: Return on Investment (ROI) Defined, Explained

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply